Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 118-133 , April 2007

Transfusion in the Patient With Sickle Cell Disease: A Critical Review of the Literature and Transfusion Guidelines

References 

  1. Platt O, Brambilla D, Rosse W, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639–1644
  2. Reed W, Vichinsky E. New considerations in the treatment of sickle cell disease. Annu Rev Med. 1998;49:461–474
  3. Nifong T, Domen R. Oxygen saturation and hemoglobin A content in patients with sickle cell disease undergoing erythrocytapheresis. Ther Apher. 2002;6:390–393
  4. Thurston G, Henderson N, Jeng M. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood. Clin Hemorheol Microcirc. 2004;30:83–97
  5. Afenyi-Annan A, Brecher M. Pre-transfusion phenotype matching for sickle cell disease patients. Transfusion. 2004;44:619–620(letter)
  6. Osby M, Shulman I. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: A survey of 1182 North American laboratories. Arch Pathol Lab Med. 2005;129:190–193
  7. The management of sickle cell disease (ed 4). Bethesda, NIH Publication 02-2117, 2002, pp 153-160.
  8. Emond A, Collis R, Darvill D, et al. Acute splenic sequestration in homozygous sickle cell disease: Natural history and management. J Pediatr. 1985;127:201–206
  9. Ohene-Frempong K, Weiner S, Sleeper L, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood. 1998;91:288–294
  10. Adams R, McKie V, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998;19:110–129
  11. Fullerton H, Adams R, Zhao S, et al. Declining stroke rates in Californian children with sickle cell disease. Blood. 2004;104:336–339
  12. Russell M, Goldberg H, Reis L, et al. Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. JAMA. 1979;242:2317–2318
  13. Adams R. Hemoglobinopathies. Hematology (Am Soc Hematol Educ Program). 2003;14–39
  14. Davies S, Luce P, Win A, et al. Acute chest syndrome in sickle-cell disease. Lancet. 1984;1:36–38
  15. Quinn C, Rogers Z, Buchanan G. Survival of children with sickle cell disease. Blood. 2004;103:4023–4027
  16. Mallouh A, Asha M. Beneficial effect of blood transfusion on children with sickle cell chest syndrome. Am J Dis Child. 1988;142:178–182
  17. Miller S, Rao S. Acute chest syndrome, transfusion, and neurologic events in children with sickle cell disease. Blood. 2003;102:1556;(letter)
  18. Henderson J, Noetzel M, McKinstry R, et al. Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood. 2003;101:415–419
  19. Hassell K, Eckman J, Lane P. Acute multiorgan failure syndrome: A potentially catastrophic complication of severe sickle cell pain episodes. Am J Med. 1994;96:155–162
  20. Haberkern C, Neumayr L, Orringer E, et al. Cholecystectomy in sickle cell anemia patients: Perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Blood. 1997;89:1543–1552
  21. Vichinsky E, Haberken C, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med. 1995;333:206–213
  22. Griffin TC, Buchanan GR. Elective surgery in children with sickle cell disease without preoperative blood transfusion. J Pediatr Surg. 1993;28:681–685
  23. Hirst C, Williamson L. Preoperative blood transfusions for sickle cell disease (Cochrane Review). In: The Cochrane Library, Issue 4. Wiley & Sons; 2006;
  24. Seargent G. In: Sickle cell disease. 2 ed.. Oxford: Oxford Medical publishers; 1992;p. 332
  25. Powars D, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med. 1978;65:461–471
  26. Peglow C, Adams R, Mckie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusion. J Pediatr. 1995;126:896–899
  27. Cohen A, Martin M, Silber J, et al. A modified transfusion program for prevention of stroke in sickle cell disease. Blood. 1992;79:1657–1661
  28. Williams J, Goff J, Anderson H, et al. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr. 1980;96:205–209
  29. Wang W, Kovnar E, Tonkin IL, et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr. 1991;118:377–382
  30. Tuck S, James C, Brewster E, et al. Prophylactic blood transfusions in maternal sickle cell syndromes. Br J Obstet Gynecol. 1987;94:121–125
  31. Koshy M. Sickle cell disease and pregnancy. Blood Rev. 1995;9:157–164
  32. Simmons B, Santhanam V, Castaner A, et al. Sickle cell heart disease: Two dimensional echo and Doppler ultrasonographic findings in the heart of adult patients with sickle cell anemia. Arch Intern Med. 1988;148:1526–1528
  33. Sutton L, Castro O, Cross D, et al. Pulmonary hypertension in sickle cell disease. Am J Cardiol. 1994;74:626–628
  34. Hankins J, Jeng M, Harris S, et al. Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol. 2005;27:158–161
  35. Vichinsky E. Pulmonary hypertension in sickle cell disease. N Engl J Med. 2004;350:857–859
  36. Gladwin M, Sachdev V, Jison M, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886–895
  37. Rifikind S, Waisman J, Thompson R, et al. RBC exchange pheresis for priapism in sickle cell disease. JAMA. 1979;242:2317–2318
  38. Miller S, Rao S, Dunn K, et al. Priapism in children with sickle cell disease. J Urol. 1995;154:844–847
  39. Platt O, Thorington B, Brambilla D, et al. Pain in sickle cell disease. N Engl J Med. 1991;325:11–16
  40. Schmalzer E, Lee J, Brown A, et al. Viscosity of mixtures of sickle cell and normal red cell at varying hematocrit levels. Transfusion. 1987;27:228–233
  41. Luban N, Strauss R, Hume H. Commentary on the safety of red cells preserved in extended storage media for neonatal transfusions. Transfusion. 1991;31:229–235
  42. Vichinsky E, Earles A, Johnson R, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990;322:1617–1621
  43. Sosler S, Jilly B, Saporito C, et al. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol. 1993;43:103–106
  44. Ambruso D, Githens J, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion. 1987;27:94–98
  45. Vichinsky E, Luban N, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial. Transfusion. 2001;41:1086–1092
  46. Tahhan H, Holbrook C, Braddy L, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion. 1994;34:562–569
  47. Castro O, Sandier G, Houston-Yu P, et al. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: Theoretical and practical implications. Transfusion. 2002;42:684–690
  48. Castellino S, Combs M, Zimmerman S, et al. Erythrocyte autoantibodies in pediatric patients with sickle cell disease receiving transfusion therapy: Frequency, characteristics, and significance. Br J Haemotol. 1999;104:189–194
  49. Friedman D, Lukas M, Jawad A, et al. Alloimmunization to platelets in heavily transfused patients with sickle cell disease. Blood. 1996;88:3216–3222
  50. Hilliard L, Williams B, Lounsbury A, et al. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients. Am J Hematol. 1998;59:28–35

PII: S0887-7963(06)00099-X

doi: 10.1016/j.tmrv.2006.11.003

Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 118-133 , April 2007

Article Tools